Philips receives FDA clearance for SpO2 sensor
Analysis based on 9 articles · First reported Jul 21, 2026 · Last updated Jul 21, 2026
The clearance reinforces Philips' position in the pulse oximetry market and may support modest revenue growth. The stock price was down 1.20% on the day, suggesting limited immediate market reaction.
Philips announced on July 21, 2026 that the U.S. United States — Food and Drug Administration (FDA) granted 510(k) clearance for its next-generation reusable Philips SpO2 clip sensor. The sensor incorporates internal optical refinements to improve signal quality and measurement consistency, achieving an Accuracy Root Mean Square (ARMS) value of 1.6%, nearly twice as accurate as the 3% level recommended by ISO. Performance was consistent across a broad range of skin tones, with accuracy varying by less than 0.5% between light and dark skin pigmentation groups. The sensor will become available in select markets globally later this year.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard